Immunome (IMNM) Enterprise Value (2023 - 2025)
Historic Enterprise Value for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to -$272.6 million.
- Immunome's Enterprise Value fell 1352.01% to -$272.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$272.6 million, marking a year-over-year decrease of 1352.01%. This contributed to the annual value of -$217.3 million for FY2024, which is 5730.41% down from last year.
- Immunome's Enterprise Value amounted to -$272.6 million in Q3 2025, which was down 1352.01% from -$268.1 million recorded in Q2 2025.
- Over the past 5 years, Immunome's Enterprise Value peaked at -$38.4 million during Q2 2023, and registered a low of -$317.3 million during Q1 2025.
- In the last 3 years, Immunome's Enterprise Value had a median value of -$240.2 million in 2024 and averaged -$201.4 million.
- In the last 5 years, Immunome's Enterprise Value plummeted by 62457.57% in 2024 and then skyrocketed by 368.35% in 2025.
- Over the past 3 years, Immunome's Enterprise Value (Quarter) stood at -$138.1 million in 2023, then tumbled by 57.3% to -$217.3 million in 2024, then fell by 25.46% to -$272.6 million in 2025.
- Its Enterprise Value stands at -$272.6 million for Q3 2025, versus -$268.1 million for Q2 2025 and -$317.3 million for Q1 2025.